Australia's most trusted
source of pharma news
Posted 12 November 2025 PM
A lack of dosage options may be contributing to a surge in poisonings from medications used to treat ADHD, with the rate of poisonings quadrupling over a decade and more than two-thirds of cases coming from just two drugs.
Researchers from Sydney University published Exposures to attention deficit hyperactivity disorder medications reported to the New South Wales Poisons Information Centre in the Australian & New Zealand Journal of Psychiatry, using nationwide data from the NSW Poisons Information Centre to detect a rise in poisonings from ADHD medications from 795 in 2014 to 3,242 in 2023.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.